Evidence map›Paper›PMID 30835943›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2019

Histologic and Transcriptional Evidence of Subclinical Synovial Inflammation in Patients With Rheumatoid Arthritis in Clinical Remission.

Dana E Orange, Phaedra Agius, Edward F DiCarlo, Serene Z Mirza, Tania Pannellini, Jackie Szymonifka, Caroline S Jiang, Mark P Figgie, Mayu O Frank, William H Robinson and 5 more

Open access · greenAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Dana E OrangeHospital for Special Surgery and Rockefeller University, New York, New York.ORCID 0000-0001-9859-7199
Phaedra AgiusNew York Genome Center, New York, New York.
Edward F DiCarloHospital for Special Surgery, New York, New York.
Serene Z MirzaHospital for Special Surgery, New York, New York.
Tania PannelliniHospital for Special Surgery, New York, New York.
Jackie SzymonifkaHospital for Special Surgery, New York, New York.
Caroline S JiangRockefeller University Hospital, New York, New York.
Mark P FiggieHospital for Special Surgery, New York, New York.
Mayu O FrankRockefeller University, New York, New York.
William H RobinsonStanford University, Stanford, California, and VA Palo Alto Health Care System, Palo Alto, California.ORCID 0000-0003-4385-704X
Laura T DonlinHospital for Special Surgery, New York, New York.
Cristina RozoHospital for Special Surgery, New York, New York.
Ellen M GravalleseUniversity of Massachusetts Memorial Medical Center, Worcester.
Vivian P BykerkHospital for Special Surgery, New York, New York.
Susan M GoodmanHospital for Special Surgery, New York, New York.
Hospital for Special Surgery · USMemorial Medical Center · USNew York Genome Center · USRockefeller University · USRockefeller University Hospital · USVA Palo Alto Health Care System · US

Funding

Disparities in COVID Disease Severity and Outcomes in New York CityUL1TR002384 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI JULIANNE L IMPERATO-MCGINLEY · 2017 to 2026
$86.2M
Clinical and Translational Science CenterUL1TR000457 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI IMPERATO-MCGINLEY, JULIANNE L · 2012 to 2016
$46.0M
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational SuccessUL1TR001866 · NCATS · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY, KRUEGER, JAMES G · 2016 to 2025
$40.6M
Molecular Pathways in Treatment Response and Flare in RAUH2AR067691 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI BYKERK, VIVIAN P, IVASHKIV, LIONEL B · 2014 to 2020
$2.0M
NCATS NIH HHS UL1 TR000457NCATS NIH HHS UL1 TR001866NCATS NIH HHS UL1 TR002384NIAMS NIH HHS UH2 AR067691The Block Family Foundation
6 · The paper itself

Abstract

objectivePatients with rheumatoid arthritis (RA) in clinical remission may have subclinical synovial inflammation. This study was undertaken to determine the proportion of patients with RA in remission or with low disease activity at the time of arthroplasty who had histologic or transcriptional evidence of synovitis, and to identify clinical features that distinguished patients as having subclinical synovitis.

methodsWe compared Disease Activity Score in 28 joints (DAS28) to synovial histologic features in 135 patients with RA undergoing arthroplasty. We also compared DAS28 scores to RNA-Seq data in a subset of 35 patients.

resultsFourteen percent of patients met DAS28 criteria for clinical remission (DAS28 <2.6), and another 15% met criteria for low disease activity (DAS28 <3.2). Histologic analysis of synovium revealed synovitis in 27% and 31% of samples from patients in remission and patients with low disease activity, respectively. Patients with low disease activity and synovitis also exhibited increased C-reactive protein (CRP) (P = 0.0006) and increased anti-cyclic citrullinated peptide (anti-CCP) antibody levels (P = 0.03) compared to patients without synovitis. Compared to patients with a "low inflammatory synovium" subtype, 183 genes were differentially expressed in the synovium of patients with subclinical synovitis. The majority of these genes (86%) were also differentially expressed in the synovium of patients with clinically active disease (DAS28 ≥3.2).

conclusionThirty-one percent of patients with low clinical disease activity exhibited histologic evidence of subclinical synovitis, which was associated with increased CRP and anti-CCP levels. Our findings suggest that synovial gene expression signatures of clinical synovitis are present in patients with subclinical synovitis.

Indexed as

AgedAnti-Citrullinated Protein AntibodiesArthritis, RheumatoidArthroplasty, Replacement, HipArthroplasty, Replacement, KneeAsymptomatic DiseasesFemaleGene Expression ProfilingHumansMaleMiddle AgedRemission InductionSequence Analysis, RNASynovial MembraneSynovitisAnti-Citrullinated Protein Antibodies

Identifiers

PMID30835943
PMCPMC6594902
OpenAlexW2918261872

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.